Biopta getting bought by Japanese firm Reprocell
DRUG development company Biopta is being bought by Japanese firm Reprocell in a deal worth around £5.5 million. The Scottish business, founded in 2002 by Dr David Bunton and Professor Chris Hillier as a spin-out from Glasgow Caledonian University, is a specialist in using human […]
Biopta getting bought by Japanese firm Reprocell Read More »
